Literature DB >> 19475496

Up-regulation of microRNA in bladder tumor tissue is not common.

Gang Wang1, Honghe Zhang, Huadong He, Wenjuan Tong, Bin Wang, Guodong Liao, Zhaodian Chen, Caigan Du.   

Abstract

MicroRNAs (miRNAs) have recently been shown to down-regulate gene expression by targeting mRNA translation and to play a critical role in tumorigenesis; how they regulate bladder tumor development, particularly in patients, is, however, poorly understood. The difference in miRNA expression in a bladder tumor compared with healthy tissue from the same patients was examined using microRNA arrays in seven patients. Here, we showed that up-regulation of miRNA was not commonly found in this limited number of patients, and four miRNAs (miR-26a, miR-29c, miR-30c, miR-30e-5p) were down-regulated as a common marker in patients with a 1-3 grade of disease. Our data suggest that instead of up-regulation of carcinogenic miRNAs, loss of regulation of these miRNA may be critical for bladder tumor development in patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475496     DOI: 10.1007/s11255-009-9584-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  34 in total

1.  Cell-type-specific signatures of microRNAs on target mRNA expression.

Authors:  Pranidhi Sood; Azra Krek; Mihaela Zavolan; Giuseppe Macino; Nikolaus Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

2.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

3.  Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.

Authors:  Christine Mayr; Michael T Hemann; David P Bartel
Journal:  Science       Date:  2007-02-22       Impact factor: 47.728

4.  let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.

Authors:  Yukihiro Akao; Yoshihito Nakagawa; Tomoki Naoe
Journal:  Biol Pharm Bull       Date:  2006-05       Impact factor: 2.233

5.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

6.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

Review 7.  Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?

Authors:  A W Tong; J Nemunaitis
Journal:  Cancer Gene Ther       Date:  2008-03-28       Impact factor: 5.987

8.  Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

Authors:  R Visone; P Pallante; A Vecchione; R Cirombella; M Ferracin; A Ferraro; S Volinia; S Coluzzi; V Leone; E Borbone; C-G Liu; F Petrocca; G Troncone; G A Calin; A Scarpa; C Colato; G Tallini; M Santoro; C M Croce; A Fusco
Journal:  Oncogene       Date:  2007-06-11       Impact factor: 9.867

9.  MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

Authors:  Shuomin Zhu; Min-Liang Si; Hailong Wu; Yin-Yuan Mo
Journal:  J Biol Chem       Date:  2007-03-15       Impact factor: 5.157

10.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

View more
  34 in total

1.  MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer.

Authors:  Xiao-hui Ling; Zhao-dong Han; Dan Xia; Hui-chan He; Fu-neng Jiang; Zhuo-yuan Lin; Xin Fu; Ye-han Deng; Qi-shan Dai; Chao Cai; Jia-hong Chen; Yu-xiang Liang; Wei-de Zhong; Chin-lee Wu
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

Review 2.  Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors.

Authors:  Annika Schaefer; Carsten Stephan; Jonas Busch; George M Yousef; Klaus Jung
Journal:  Nat Rev Urol       Date:  2010-04-06       Impact factor: 14.432

3.  Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population.

Authors:  Yong-ping Mu; Xiu-lan Su
Journal:  Med Oncol       Date:  2011-11-23       Impact factor: 3.064

4.  A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells.

Authors:  Angela Y Jia; Mireia Castillo-Martin; Josep Domingo-Domenech; Dennis M Bonal; Marta Sánchez-Carbayo; Jose M Silva; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2013-02-12       Impact factor: 4.307

5.  Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.

Authors:  Darina Kachakova; Atanaska Mitkova; Elenko Popov; Ivan Popov; Alexandrina Vlahova; Tihomir Dikov; Svetlana Christova; Vanio Mitev; Chavdar Slavov; Radka Kaneva
Journal:  DNA Cell Biol       Date:  2014-12-18       Impact factor: 3.311

6.  Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer.

Authors:  Hung-Lung Ke; Meng Chen; Yuanqing Ye; Michelle A T Hildebrandt; Wen-Jeng Wu; Hua Wei; Maosheng Huang; David W Chang; Colin P Dinney; Xifeng Wu
Journal:  Carcinogenesis       Date:  2013-01-14       Impact factor: 4.944

7.  The role of miR-26 in tumors and normal tissues (Review).

Authors:  Jie Gao; Qing-Guang Liu
Journal:  Oncol Lett       Date:  2011-09-05       Impact factor: 2.967

Review 8.  Aberrant expression of microRNAs in bladder cancer.

Authors:  Hirofumi Yoshino; Naohiko Seki; Toshihiko Itesako; Takeshi Chiyomaru; Masayuki Nakagawa; Hideki Enokida
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

Review 9.  The evolving understanding of microRNA in bladder cancer.

Authors:  Elizabeth A Guancial; Joaquim Bellmunt; Shuyuan Yeh; Jonathan E Rosenberg; David M Berman
Journal:  Urol Oncol       Date:  2013-08-02       Impact factor: 3.498

Review 10.  The role of microRNA-26a in human cancer progression and clinical application.

Authors:  Jing Chen; Kai Zhang; Yuejuan Xu; Yanping Gao; Chen Li; Rui Wang; Longbang Chen
Journal:  Tumour Biol       Date:  2016-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.